Close
  • Latest News
  • Artificial Intelligence
  • Video
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
Read Down
Sign in
Close
Welcome!Log into your account
Forgot your password?
Read Down
Password recovery
Recover your password
Close
Search
Logo
Logo
  • Latest News
  • Artificial Intelligence
  • Video
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
More
    Home Applications
    • Applications

    Biotech Conference Faces Down Critics

    Written by

    Stacy Lawrence
    Published June 10, 2004
    Share
    Facebook
    Twitter
    Linkedin

      eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More.

      SAN FRANCISCO—The annual BIO conference of the Biotechnology Industry Organization made a splash here, on the streets as well as in the expo hall. The event gathered more than 16,000 attendees and, by some counts, several hundred protestors.

      The crowd picketing the BIO 2004 conference made it very clear that the public has many concerns about biotechnology. The demonstration shut down traffic in the downtown area for several hours Tuesday. By Thursday, the tally of arrests totaled about 150 people, and a dozen people were still in custody.

      One protestor near the hall yelled that it made little sense for developed nations to promote obesity and then profit from selling obesity treatment. This “unhealthy lifestyle,” demonstrators said, is supported by corporate strategies and government policies, which then must be addressed through expensive medications.

      Another popular target of the protest was agricultural biotechnology for its perceived ecological consequences and economic ramifications within developing nations.

      To little surprise, the biotech executives disregarded the concerns. They uniformly saw education as the best way to address the complaints of the protestors jeering at attendees.

      “The public should see scientists as part of society, rather than being outside of it,” offered James Mullen, CEO of Biogen Idec Inc. following Tuesdays demonstration.

      The conference covered many facets of biotechnology, from the drug creation and agricultural products on the minds of protesters to the use of IT in medicine.

      One hot topic was the optimization of genomic searching for drugs and the creation of a biological database, or “biobank.”

      While pharmaceutical and biotechnology companies have spent many billions to obtain information on the genetic variations associated with the emergence of particular diseases, the going is still slow. Only 10 percent of the drug molecules that start out in the research pipeline actually make it to market, according to data presented at the conference.

      Francis Collins, director of the National Human Genome Research Institute, called for the establishment of a biobank in the United States. The goal would be a publicly accessible database containing the biological material of at least half a million people, he said. It would allow scientists to track diseased and nondiseased populations, as well as to access data on an individual preceding the onset of disease.

      /zimages/1/28571.gifClick here to read more about the biobank.

      “If the public understood the benefits and potential benefits of biotechnology, they would fear it less,” said Leroy Hood, president of the Institute for Systems Biology in Seattle.

      One BIO project that seeks to improve that standing with the public will be the BIO Ventures for Global Health (BVGH), announced Monday. The new nonprofit organization will target neglected diseases and said it has received a $1 million startup grant from the Bill & Melinda Gates Foundation.

      Carl Feldbaum, the president of BIO since its inception with the merging of two smaller trade groups in 1993, announced the formation of BVGH in his keynote address.

      He acknowledged that the bounties and benefits of biotechnology have been limited largely to developed countries. Remedying this inequity, particularly in the face of the epidemics of AIDS, malaria and yellow fever, has become a glaring priority, he said.

      Meanwhile, Secretary of Health and Human Services Tommy Thompson was upbeat on the future of biotech. He discussed the recent mandatory moves toward bar codes on drugs and moves toward the use of RFID (radio-frequency identification) tags in medical applications.

      /zimages/1/28571.gifRead more here about Thompsons address to the BIO conference.

      The several-year slowdown of technology-sector growth served as the backdrop to this enthusiasm for biotech. San Francisco Mayor Gavin Newsom stumped for the return of major biotech companies to the city. He promised tax breaks along with other perks.

      But Newsom was hardly alone, as economic development groups from dozens of states and countries around the world were out in force and dominated the showroom floor. Although biotech has a limited economic impact now, clearly many are banking on its future as a growth industry.

      /zimages/1/28571.gifCheck out eWEEK.coms Enterprise Applications Center at http://enterpriseapps.eweek.com for the latest news, reviews and analysis about productivity and business solutions.

      /zimages/1/77042.gif

      Be sure to add our eWEEK.com enterprise applications news feed to your RSS newsreader or My Yahoo page

      Stacy Lawrence
      Stacy Lawrence
      Stacy Lawrence is co-editor of CIOInsight.com's Health Care Center. Lawrence has covered IT and the life sciences for various publications, including Business 2.0, Red Herring, The Industry Standard and Nature Biotechnology. Before becoming a journalist, Lawrence attended New York University and continued on in the sociology doctoral program at UC Berkeley.

      Get the Free Newsletter!

      Subscribe to Daily Tech Insider for top news, trends & analysis

      Get the Free Newsletter!

      Subscribe to Daily Tech Insider for top news, trends & analysis

      MOST POPULAR ARTICLES

      Artificial Intelligence

      9 Best AI 3D Generators You Need...

      Sam Rinko - June 25, 2024 0
      AI 3D Generators are powerful tools for many different industries. Discover the best AI 3D Generators, and learn which is best for your specific use case.
      Read more
      Cloud

      RingCentral Expands Its Collaboration Platform

      Zeus Kerravala - November 22, 2023 0
      RingCentral adds AI-enabled contact center and hybrid event products to its suite of collaboration services.
      Read more
      Artificial Intelligence

      8 Best AI Data Analytics Software &...

      Aminu Abdullahi - January 18, 2024 0
      Learn the top AI data analytics software to use. Compare AI data analytics solutions & features to make the best choice for your business.
      Read more
      Latest News

      Zeus Kerravala on Networking: Multicloud, 5G, and...

      James Maguire - December 16, 2022 0
      I spoke with Zeus Kerravala, industry analyst at ZK Research, about the rapid changes in enterprise networking, as tech advances and digital transformation prompt...
      Read more
      Video

      Datadog President Amit Agarwal on Trends in...

      James Maguire - November 11, 2022 0
      I spoke with Amit Agarwal, President of Datadog, about infrastructure observability, from current trends to key challenges to the future of this rapidly growing...
      Read more
      Logo

      eWeek has the latest technology news and analysis, buying guides, and product reviews for IT professionals and technology buyers. The site’s focus is on innovative solutions and covering in-depth technical content. eWeek stays on the cutting edge of technology news and IT trends through interviews and expert analysis. Gain insight from top innovators and thought leaders in the fields of IT, business, enterprise software, startups, and more.

      Facebook
      Linkedin
      RSS
      Twitter
      Youtube

      Advertisers

      Advertise with TechnologyAdvice on eWeek and our other IT-focused platforms.

      Advertise with Us

      Menu

      • About eWeek
      • Subscribe to our Newsletter
      • Latest News

      Our Brands

      • Privacy Policy
      • Terms
      • About
      • Contact
      • Advertise
      • Sitemap
      • California – Do Not Sell My Information

      Property of TechnologyAdvice.
      © 2024 TechnologyAdvice. All Rights Reserved

      Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.

      ×